Faculty Publications

As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of Touro University, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to touro.scholar@touro.edu.

Total number of publications: 7,082

Enter a faculty name:

or browse faculty by school:

Administrative Offices

Graduate Schools

Health Sciences

Lander Colleges

Law Center

New York School of Career and Applied Studies (NYSCAS)

Touro University System

Reset
First Prev 44 45 46 47 48 49 50 51 52 53 Next Last

  • Chu, S., Zhou, G., & Gochin, M. (2017). Evaluation of ligand-based NMR screening methods to characterize small molecule binding to HIV-1 glycoprotein-41. Organic & Biomolecular Chemistry, 15(24), 5210-5219. This material can be found here.

  • Chu, Y., Brand, P., Morris, E., Lee, F., Talano, J. M., Shenoy, S., . . . Cairo, M. S. (2016). Natural killer cell reconstitution following familial haploidentical (FHI) CD34 enriched stem cell transplantation with T-cell add back in patients with high risk sickle cell disease (SCD) (IND 14359). Biology of Blood and Marrow Transplantation, 22(3), S151-S152. doi:10.1016/j.bbmt.2015.11.502

    		•

  • Chu, Y., Flower, A., & Cairo, M. S. (2016). Modification of expanded NK cells with chimeric antigen receptor mRNA for adoptive cellular therapy. Methods in Molecular Biology, 1441, 215-230. doi:10.1007/978-1-4939-3684-7_18

    		•

  • Chu, Y., Hochberg, J., Yahr, A., Ayello, J., Van De Ven, C., Barth, M., . . . Cairo, M. S. (2015). Targeting CD20+ aggressive B-cell non-Hodgkin lymphoma by anti-CD20 CAR mRNA-modified expanded natural killer cells in vitro and in NSG mice. Cancer Immunology Research, 3(4), 333-344. doi:10.1158/2326-6066.CIR-14-0114

    		•

  • Chu, Y., Lee, F., Ayello, J., Hang, B., Zhang, M., Wong, H., . . . Cairo, M. (2016). Therapeutic effects of Alt-803, an IL-15 superagonist, in combination with anti-CD20 chimeric antigen receptor modified expanded natural killer cells against Burkitt lymphoma (BL). Cytotherapy, 18(6), S59. doi:10.1016/j.jcyt.2016.03.194

    		•

  • Chu, Y., Lee, F., Ayello, J., Hang, B., Zhang, M., Wong, H., . . . Cairo, M. S. (2016). Therapeutic effects of Alt-803, an IL-15 superagonist, in combination with anti-CD20 chimeric antigen receptor modified expanded natural killer cells against Burkitt lymphoma (BL). Biology of Blood and Marrow Transplantation, 22(3), S151. doi:10.1016/j.bbmt.2015.11.501

    		•

  • Chu, Y., Lee, F., Hamby, C., Misarti, J., Hang, B., Ayello, J., . . . Cairo, M. (2016). Regulation of cytokine release and anti-tumor effect of anti-CD20 CAR modified expanded natural killer cells by Alt-803, an IL-15 superagonist. Experimental Hematology, 44(9), S64. doi:10.1016/j.exphem.2016.06.107

    		•

  • Chu, Y., Yahr, A., Ayello, J., Van de Ven, C., & Cairo, M. (2014). Therapeutic effects of romidepsin, a histone deacetylase inhibitor (HDACI), alone and in combination with natural killer cells against pediatric Burkitt lymphoma. Pediatric Blood and Cancer, 61(S2), S138.

  • Chu, Y., Yahr, A., Ayello, J., Van De Ven, C., Barth, M., Czuczman, M., & Cairo, M. S. (2014). Anti-CD20 chimeric antigen receptor (CAR) modified expanded natural killer (NK) cells significantly mediate rituximab sensitive and resistant Burkitt lymphoma (BL) regression and improve survival in human BL xenografted NSG mice. Biology of Blood and Marrow Transplantation, 20(2 Suppl), S257.

  • Chu, Y., Yahr, A., Cheng, B., Hang, B., Ayello, J., Barth, M., & Cairo, M. S. (2016). Enhanced in-vitro and in-vivo targeting of rituximab sensitive and resistant Burkitt lymphoma (BL) by anti-CD20 chimeric antigen receptor (CAR) modified expanded natural killer cells in combination with a histone deacetylase inhibitor, romidepsin. Biology of Blood and Marrow Transplantation, 22(3), S392. doi:10.1016/j.bbmt.2015.11.915

    		•

  • Chu, Y., Yahr, A., Cheng, B., Hang, B., Ayello, J., Barth, M., & Cairo, M. S. (2016). Enhanced in-vitro and in-vivo targeting of rituximab sensitive and resistant Burkitt lymphoma (BL) by anti-CD20 chimeric antigen receptor (CAR) modified expanded natural killer cells in combination with a histone deacetylase inhibitor, romidepsin. Pediatric Blood & Cancer, 63(Suppl S1), S96.

  • Chua, A. T., Zelnick, J. R., O'Donnell, M. R., & Meissner, J. S. (2014). Healthcare provider perspectives on barriers to tuberculosis care and treatment among foreign-born populations in New York City [Supplemental material]. American Journal of Respiratory and Critical Care Medicine, 189, B51. This material can be found here.

  • Chui, T. Y., Dubow, M., Pinhas, A., Shah, N., Gan, A., Weitz, R., . . . Rosen, R. B. (2014). Comparison of adaptive optics scanning light ophthalmoscopic fluorescein angiography and offset pinhole imaging. Ophthalmology, 5(4), 1173-1189. doi:10.1364/BOE.5.001173

    		•

  • Chung, K. M., & Amar, S. (1995). Molecular and cellular biology research in periodontal regeneration and its clinical implication. Annals of the Academy of Medicine Singapore, 24(1), 58-67.

  • Chur, V., Small, C. B., Stryszak, P., & Teper, A. (2013). Safety of mometasone furoate nasal spray in the treatment of nasal polyps in children. Pediatric Allergy & Immunology, 24(1), 33-38. doi:10.1111/pai.12032

    		•

  • Chyan, A., Yang, J., & Lin, A. W. (2014). Serving Taiwan's remote mountain regions and beyond Taiwan. Journal of the American Osteopathic Association, 114(1), e68. This material can be found here.

  • Ciervo, C. A., Shubrook, J. H., & Grundy, P. (2015). Diabetes management within evolving health care delivery models: The osteopathic perspective [Supplemental material]. Journal of the American Osteopathic Association, 115, eS5-eS7. This material can be found here.

  • Ciervo, C. A., Shubrook, J. H., & Grundy, P. (2015). Leveraging the principles of osteopathic medicine to improve diabetes outcomes within a new era of health care reform [Supplemental material]. Journal of the American Osteopathic Association, 115, eS8-eS19. This material can be found here.

  • Cil, A. P., Bang, H., & Oktay, K. (2013). Age-specific probability of live birth with oocyte cryopreservation: An individual patient data meta-analysis. Fertility & Sterility, 100(2), 492-9.e3. doi:10.1016/j.fertnstert.2013.04.023

    		•

  • Cimica, V., Boigard, H., Bhatia, B., Fallon, J. T., Alimova, A., Gottlieb, P., & Galarza, J. M. (2016). Novel respiratory syncytial virus-like particle vaccine composed of the postfusion and prefusion conformations of the F glycoprotein. Clinical and Vaccine Immunology, 23(6), 451-459. doi:10.1128/CVI.00720-15

    		•

  • Cimini, C., Corrada, R., Burleson, M., Berman, M., Brown, C. C., & Kruse, K. (2015). Creative initiatives at U.S. law schools. In Experience the future: Papers from the Second National Symposium on Experiential Education in Law: Alliance for Experiential Learning in Law. Elon Law Review, 7(1), 57-88. This material can be found here.

  • Cioffi, W. G., Adams, J.,C.A., Biffl, W. L., Asensio, J. A., Connolly, M. D., Jurkovich, G. J., & Britt, L. D. (Eds.). (2014). Atlas of trauma/emergency surgical techniques. Philadelphia, PA: Saunders.

  • Citrome, L. (2013). A review of the pharmacology, efficacy and tolerability of recently approved and upcoming oral antipsychotics: An evidence-based medicine approach. CNS Drugs, 27(11), 879-911. doi:10.1007/s40263-013-0105-7

    		•

  • Citrome, L. (2013). Addressing the need for rapid treatment of agitation in schizophrenia and bipolar disorder: Focus on inhaled loxapine as an alternative to injectable agents. Therapeutics and Clinical Risk Management, 9, 235-245. doi:10.2147/TCRM.S31484

    		•

  • Citrome, L. (2013). Cariprazine: Chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerability. Expert Opinion on Drug Metabolism and Toxicology, 9(2), 193-206. doi:10.1517/17425255.2013.759211

    		•
First Prev 44 45 46 47 48 49 50 51 52 53 Next Last